Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Of Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07206589
What this trial is testing

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
Mayo Clinic 1,010
Early research (Phase 1)Looking for participantsNCT07544589
What this trial is testing

Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Who this might be right for
Colorectal CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+1 more
Dispatch Biotherapeutics 66
Not applicableEnded earlyNCT00430027
What this trial is testing

Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma

Who this might be right for
Esophageal Adenocarcinoma
University of Colorado, Denver 8
Large-scale testing (Phase 3)Study completedNCT00002631
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 298
Testing effectiveness (Phase 2)Temporarily pausedNCT00048529
What this trial is testing

Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus

Who this might be right for
Gastric CancerEsophageal Neoplasms
Tularik 70
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Not applicableStudy completedNCT04408105
What this trial is testing

Survey Study on Barrett's Esophagus Screening

Who this might be right for
Gastroesophageal Reflux DiseaseBarrett's EsophagusEsophagus Adenocarcinoma
University of Colorado, Denver 725
Testing effectiveness (Phase 2)Study completedNCT01630083
What this trial is testing

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma
Astellas Pharma Global Development, Inc. 252
Testing effectiveness (Phase 2)Ended earlyNCT00177255
What this trial is testing

Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

Who this might be right for
Cancer
University of Pittsburgh 40
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05480384
What this trial is testing

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

Who this might be right for
Esophageal AdenocarcinomaEsophageal CancerHER-2 Protein Overexpression+1 more
Brown University 1
Large-scale testing (Phase 3)Ended earlyNCT02551458
What this trial is testing

Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy

Who this might be right for
Epidermoid Carcinoma orAdenocarcinoma of the Thoracic Oesophagus orAdenocarcinoma of the Oesogastric Junction (Siewert Type I or II)+1 more
Centre Hospitalier Universitaire Dijon 188
Testing effectiveness (Phase 2)Study completedNCT00006081
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
M.D. Anderson Cancer Center 37
Not applicableLooking for participantsNCT07675967
What this trial is testing

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Who this might be right for
Lung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more
Dana-Farber Cancer Institute 5,000
Early research (Phase 1)Study completedNCT01561014
What this trial is testing

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more
Wake Forest University Health Sciences 9
Not applicableStudy completedNCT00795184
What this trial is testing

Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy

Who this might be right for
Barrett SyndromeBarrett's SyndromeBarrett's Esophagus+2 more
Mauna Kea Technologies 122
Testing effectiveness (Phase 2)Study completedNCT00217087
What this trial is testing

Endoscopic Therapy of Early Cancer in Barretts Esophagus

Who this might be right for
Early Stage Esophageal AdenocarcinomaBarrett Esophagus
Mayo Clinic 73
Testing effectiveness (Phase 2)Ended earlyNCT01307956
What this trial is testing

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal AdenocarcinomaStage IIA Esophageal Cancer+1 more
University of Nebraska 11
Testing effectiveness (Phase 2)Looking for participantsNCT06687876
What this trial is testing

Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy

Who this might be right for
Oesophageal AdenocarcinomaTumor Microenvironment
Amsterdam UMC, location VUmc 14
Testing effectiveness (Phase 2)Study completedNCT03777813
What this trial is testing

Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer

Who this might be right for
Esophagus CancerUnresectable Malignant Neoplasm
UNICANCER 112
Next Page